Recent Updates
Recently added Catalysts
VANI Neutral Sentiment

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Key Takeaway: Vivani Medical has released its financial results for the first quarter of 2026. The report includes a business update, although specific details regarding financial performance or strategic initiatives were not provided in the article. The announcement is part of the company's ongoing communication with stakeholders.
Price reaction · baseline $1.16 (2026-05-13 close) · hit after-hours · clean, no other VANI news in the window
day 0 close · peak
+3.4%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+69%
120-day peak, hindsight
Typical move
3.2%
average across 2 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Exenatide
Phase 1 · Overweight and Obesity

Full Press Release Details

Blog Post
vivani | May 13, 2026
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Read More
Previous Article
Next Article
Blog Navigation
Last updated: May 13, 2026